News tagged with velcade
Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer
(PhysOrg.com) -- A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today ...
Nov 05, 2009 |
not rated yet |
0
Search results for velcade
Study finds bortezomib to be promising treatment for rheumatoid arthritis
A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis ...
Medicine & Health / Diseases, Conditions, Syndromes
Nov 03, 2010 |
5 / 5 (1) |
0
Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma
A new study by researchers from the John Theurer Cancer Center at Hackensack University Medical Center sheds light on how bortezomib (VELCADE), the first in a new class of cancer drugs known as proteasome inhibitors, works ...
Jul 12, 2010 |
5 / 5 (2) |
0
Cancer wins may be bigger than they seem
(AP) -- Doctors reported gains against nearly every form of cancer at a conference that ended this week. Yet when Will Thomas heard about an advance against prostate cancer, he wanted to know just one thing: "Is it a cure?"
Jun 09, 2010 |
5 / 5 (1) |
0
New myeloma drug shows promise in early testing
A drug designed to target cancerous plasma cells appears promising in treating multiple myeloma, a type of blood cancer.
Jun 07, 2010 |
4 / 5 (1) |
0
Researchers find new method of fixing broken proteins to treat genetic diseases
Researchers at Fox Chase Cancer Center have demonstrated how it could be possible to treat genetic diseases by enhancing the natural ability of cells to restore their own mutant proteins. In particular, they found that drugs ...
Jan 15, 2010 |
4.7 / 5 (3) |
0
Drug shows promise as new treatment for gut tumor
A drug that is already an approved therapy for some cancers also might be an effective secondary treatment for a rare tumor of the gastrointestinal tract, according to a team led by researchers from the University of Pittsburgh ...
Jan 11, 2010 |
not rated yet |
0
Multiple myeloma patients experience high response rate with new 3-drug combination
A new three-drug combination has shown in a phase 1/2 clinical trial that it is a "highly effective regimen" in the treatment of patients newly diagnosed with multiple myeloma, a cancer of white blood cells in bone marrow, ...
Dec 06, 2009 |
not rated yet |
0
Experimental drug lets B cells live and lymphoma cells die
(PhysOrg.com) -- An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental He ...
Medicine & Health / Medical research
Sep 21, 2009 |
not rated yet |
0
Inhibition of NF-kappa B, a key inflammatory protein, reduced radiation toxicity in zebrafish
Directly inhibiting the activity of a key protein mediator of inflammation reduced radiation toxicity in zebrafish embryos, and may ultimately be of help to patients receiving radiation therapy, according to researchers from ...
Sep 01, 2009 |
not rated yet |
0
Finding may explain anti-cancer activity of thiazole antibiotics
University of Illinois at Chicago College of Medicine researchers have discovered how some recently approved drugs act against cancer cells. The finding may lead to a more effectively targeted anti-cancer strategy.
Aug 12, 2009 |
not rated yet |
0
List of search results for velcade
